A detailed history of Hurlow Wealth Management Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Hurlow Wealth Management Group, Inc. holds 2,969 shares of NVS stock, worth $308,211. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,969
Previous 2,969 -0.0%
Holding current value
$308,211
Previous $316,000 7.91%
% of portfolio
0.11%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$92.57 - $107.37 $925 - $1,073
-10 Reduced 0.34%
2,969 $316,000
Q1 2024

Apr 15, 2024

BUY
$95.27 - $108.47 $952 - $1,084
10 Added 0.34%
2,979 $288,000
Q3 2022

Oct 13, 2022

SELL
$74.61 - $87.26 $4,103 - $4,799
-55 Reduced 1.82%
2,969 $226,000
Q1 2022

Apr 13, 2022

SELL
$80.11 - $90.62 $24,193 - $27,367
-302 Reduced 9.08%
3,024 $265,000
Q4 2021

Feb 02, 2022

SELL
$79.7 - $88.13 $62,484 - $69,093
-784 Reduced 19.08%
3,326 $301,000
Q3 2021

Oct 08, 2021

BUY
$81.78 - $95.14 $88,813 - $103,322
1,086 Added 35.91%
4,110 $336,000
Q2 2021

Jul 22, 2021

SELL
$85.24 - $94.15 $3,409 - $3,766
-40 Reduced 1.31%
3,024 $276,000
Q1 2021

Apr 20, 2021

BUY
$83.5 - $98.47 $3,340 - $3,938
40 Added 1.32%
3,064 $262,000
Q3 2020

Oct 27, 2020

SELL
$82.14 - $91.0 $4,764 - $5,278
-58 Reduced 1.88%
3,024 $263,000
Q2 2020

Jul 15, 2020

SELL
$80.93 - $91.1 $8,659 - $9,747
-107 Reduced 3.36%
3,082 $265,000
Q1 2020

Apr 16, 2020

SELL
$70.67 - $99.01 $22,049 - $30,891
-312 Reduced 8.91%
3,189 $273,000
Q1 2019

May 03, 2019

SELL
$75.32 - $86.15 $12,653 - $14,473
-168 Reduced 4.58%
3,501 $288,000
Q4 2018

Feb 01, 2019

BUY
$73.66 - $82.02 $270,258 - $300,931
3,669 New
3,669 $314,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hurlow Wealth Management Group, Inc. Portfolio

Follow Hurlow Wealth Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hurlow Wealth Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hurlow Wealth Management Group, Inc. with notifications on news.